Showing results (151-160 of 569) with videos related to
Sort By:
Pageof 57
JCO Precision Oncology|September 10, 2019
Multigene Hereditary Cancer Panels Reveal High-Risk Pancreatic Cancer Susceptibility GenesChunling Hu, Holly LaDuca, Hermela Shimelis, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 21, 2009
Genetic variation in the chromosome 17q23 amplicon and breast cancer riskLinda E Kelemen, Xianshu Wang, Zachary S Fredericksen, et al.Breast Cancer Research and Treatment|September 28, 2006
A comprehensive examination of CYP19 variation and risk of breast cancer using two haplotype-tagging approachesJanet E Olson, James N Ingle, Cynthia X Ma, et al.Cancer Research Communications|April 29, 2025
Breast Cancer Risk Modification in Women with Pathogenic Variants in BRCA1, BRCA2, ATM, CHEK2, and PALB2Allison W Kurian, Elisha Hughes, Ryan Bernhisel, et al.Breast Cancer Research : BCR|November 17, 2012
The influence of mammogram acquisition on the mammographic density and breast cancer association in the Mayo Mammography Health Study cohortJanet E Olson, Thomas A Sellers, Christopher G Scott, et al.Journal of the National Cancer Institute|July 9, 2018
Risk of Different Cancers Among First-degree Relatives of Pancreatic Cancer Patients: Influence of Probands' Susceptibility Gene Mutation StatusSamuel O Antwi, Sarah E Fagan, Kari G Chaffee, et al.Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|November 25, 2017
Identification of a pyruvate-to-lactate signature in pancreatic intraductal papillary mucinous neoplasmsAlan R Penheiter, Dinesh K Deelchand, Emily Kittelson, et al.Investigational New Drugs|September 2, 2018
A phase I study of the farnesyltransferase inhibitor Tipifarnib in combination with the epidermal growth factor tyrosine kinase inhibitor Erlotinib in patients with advanced solid tumorsKhalid Jazieh, Julian Molina, Jacob Allred, et al.Cancer Research|July 5, 2002
TBX2 is preferentially amplified in BRCA1- and BRCA2-related breast tumorsColleen S Sinclair, Camilo Adem, Ali Naderi, et al.Cancer Prevention Research (Philadelphia, Pa.)|October 24, 2020
Impact of Personalized Genetic Breast Cancer Risk Estimation With Polygenic Risk Scores on Preventive Endocrine Therapy Intention and UptakeJulian O Kim, Daniel J Schaid, Celine M Vachon, et al.Pageof 57